Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu dopisy
PubMed
35662289
DOI
10.1111/cea.14182
Knihovny.cz E-zdroje
- MeSH
- bradykinin analogy a deriváty terapeutické užití MeSH
- hereditární angioedémy * diagnóza farmakoterapie MeSH
- inhibiční protein komplementu C1 genetika terapeutické užití MeSH
- lidé MeSH
- registrace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- Názvy látek
- bradykinin MeSH
- icatibant MeSH Prohlížeč
- inhibiční protein komplementu C1 MeSH
Department of Immunology and Allergology Teaching Hospital Pilsen Czech Republic
Department of Immunology University Hospital in Motol Charles University Prague Czech Republic
Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic
Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Biostatistics and Analyses Ltd Brno Czech Republic
International Clinical Research Centre St Anne's University Hospital Brno Czech Republic
Zobrazit více v PubMed
Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update. Allergy. 2022. doi:10.1111/all.15214
R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021. https://www.R-project.org/
Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med. 2003;163(10):1229-1235.
Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130(3):692-697.
Longhurst HJ, Aberer W, Bouillet L, et al. The Icatibant outcome survey: treatment of laryngeal angioedema attacks. Eur J Emerg Med. 2016;23(3):224-227.
Craig TJ, Wasserman RL, Levy RJ, et al. Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema. J Clin Immunol. 2010;30(6):823-829.
Bork K, Bernstein JA, Machnig T, Craig TJ. Efficacy of different medical therapies for the treatment of acute laryngeal attacks of hereditary angioedema due to C1-esterase inhibitor deficiency. J Emerg Med. 2016;50(4):567-580.
Moldovan D, Reshef A, Fabiani J, et al. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Clin Exp Allergy. 2012;42(6):929-935.
Baş M, Greve J, Hoffmann TK, et al. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study. Allergy. 2013;68(11):1452-1459.
Malbrán A, Riedl M, Ritchie B, et al. Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial. Clin Exp Immunol. 2014;177(2):544-553.
